Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022784448> ?p ?o ?g. }
- W2022784448 endingPage "248S" @default.
- W2022784448 startingPage "242S" @default.
- W2022784448 abstract "Lung cancer staging, based on anatomic extent of disease and described by the TNM staging system (T, primary tumor; N, regional lymph nodes; M, distant metastasis), is an important parameter for determining the clinical course of this disease. To evaluate the prognostic importance of TNM staging for lung cancer, we conducted a retrospective study analyzing survival rates according to TNM staging in 2,382 patients who had pulmonary resection for non-small cell lung cancer. Postoperatively, 3 patients were classified in stage 0, 796 in stage I, 304 in stage II, 719 in stage IIIA, 233 in stage IIIB, and 327 in stage IV. The 5-year survival rates for these patients were as follows: stage I, 68.5%; stage II, 46.9%; stage IIIA, 26.1%; stage IIIB, 9.0%; and stage IV, 11.2% (including ipsilateral, intrapulmonary metastases); 5-year survival rates for 140 patients with stage IV disease with intrapulmonary metastases in either the same lobe or another ipsilateral lobe were 17.8% and 8.3%, respectively. There was prognostic significance between stage I and stage II disease, stage II and stage IIIA disease, and stage IIIA and stage IIIB disease, but not between stage IIIB and stage IV disease. Only a few modifications will be required for the TNM staging system, which at present accurately reflects the prognosis of patients with lung cancer and is helpful in determining treatment. Lung cancer staging, based on anatomic extent of disease and described by the TNM staging system (T, primary tumor; N, regional lymph nodes; M, distant metastasis), is an important parameter for determining the clinical course of this disease. To evaluate the prognostic importance of TNM staging for lung cancer, we conducted a retrospective study analyzing survival rates according to TNM staging in 2,382 patients who had pulmonary resection for non-small cell lung cancer. Postoperatively, 3 patients were classified in stage 0, 796 in stage I, 304 in stage II, 719 in stage IIIA, 233 in stage IIIB, and 327 in stage IV. The 5-year survival rates for these patients were as follows: stage I, 68.5%; stage II, 46.9%; stage IIIA, 26.1%; stage IIIB, 9.0%; and stage IV, 11.2% (including ipsilateral, intrapulmonary metastases); 5-year survival rates for 140 patients with stage IV disease with intrapulmonary metastases in either the same lobe or another ipsilateral lobe were 17.8% and 8.3%, respectively. There was prognostic significance between stage I and stage II disease, stage II and stage IIIA disease, and stage IIIA and stage IIIB disease, but not between stage IIIB and stage IV disease. Only a few modifications will be required for the TNM staging system, which at present accurately reflects the prognosis of patients with lung cancer and is helpful in determining treatment." @default.
- W2022784448 created "2016-06-24" @default.
- W2022784448 creator A5023175666 @default.
- W2022784448 creator A5023442613 @default.
- W2022784448 creator A5058699623 @default.
- W2022784448 creator A5062012032 @default.
- W2022784448 creator A5080015561 @default.
- W2022784448 date "1997-10-01" @default.
- W2022784448 modified "2023-10-11" @default.
- W2022784448 title "Implications of Staging in Lung Cancer" @default.
- W2022784448 cites W1880563141 @default.
- W2022784448 cites W1972065006 @default.
- W2022784448 cites W1972240628 @default.
- W2022784448 cites W1975549289 @default.
- W2022784448 cites W1977028906 @default.
- W2022784448 cites W1987187775 @default.
- W2022784448 cites W2015353949 @default.
- W2022784448 cites W2038103977 @default.
- W2022784448 cites W2042691811 @default.
- W2022784448 cites W2047461796 @default.
- W2022784448 cites W2051612319 @default.
- W2022784448 cites W2104325484 @default.
- W2022784448 cites W2130366077 @default.
- W2022784448 cites W2130550934 @default.
- W2022784448 cites W2131928292 @default.
- W2022784448 cites W2324856818 @default.
- W2022784448 cites W2462748410 @default.
- W2022784448 cites W4321429460 @default.
- W2022784448 cites W4328000885 @default.
- W2022784448 cites W92559662 @default.
- W2022784448 doi "https://doi.org/10.1378/chest.112.4_supplement.242s" @default.
- W2022784448 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9337297" @default.
- W2022784448 hasPublicationYear "1997" @default.
- W2022784448 type Work @default.
- W2022784448 sameAs 2022784448 @default.
- W2022784448 citedByCount "103" @default.
- W2022784448 countsByYear W20227844482012 @default.
- W2022784448 countsByYear W20227844482013 @default.
- W2022784448 countsByYear W20227844482014 @default.
- W2022784448 countsByYear W20227844482015 @default.
- W2022784448 countsByYear W20227844482016 @default.
- W2022784448 countsByYear W20227844482018 @default.
- W2022784448 countsByYear W20227844482023 @default.
- W2022784448 crossrefType "journal-article" @default.
- W2022784448 hasAuthorship W2022784448A5023175666 @default.
- W2022784448 hasAuthorship W2022784448A5023442613 @default.
- W2022784448 hasAuthorship W2022784448A5058699623 @default.
- W2022784448 hasAuthorship W2022784448A5062012032 @default.
- W2022784448 hasAuthorship W2022784448A5080015561 @default.
- W2022784448 hasConcept C121608353 @default.
- W2022784448 hasConcept C126322002 @default.
- W2022784448 hasConcept C126838900 @default.
- W2022784448 hasConcept C141071460 @default.
- W2022784448 hasConcept C142724271 @default.
- W2022784448 hasConcept C143998085 @default.
- W2022784448 hasConcept C146357865 @default.
- W2022784448 hasConcept C151730666 @default.
- W2022784448 hasConcept C2776256026 @default.
- W2022784448 hasConcept C2776808855 @default.
- W2022784448 hasConcept C2777693549 @default.
- W2022784448 hasConcept C2779720271 @default.
- W2022784448 hasConcept C2779961022 @default.
- W2022784448 hasConcept C2780325254 @default.
- W2022784448 hasConcept C2993415550 @default.
- W2022784448 hasConcept C71924100 @default.
- W2022784448 hasConcept C86803240 @default.
- W2022784448 hasConceptScore W2022784448C121608353 @default.
- W2022784448 hasConceptScore W2022784448C126322002 @default.
- W2022784448 hasConceptScore W2022784448C126838900 @default.
- W2022784448 hasConceptScore W2022784448C141071460 @default.
- W2022784448 hasConceptScore W2022784448C142724271 @default.
- W2022784448 hasConceptScore W2022784448C143998085 @default.
- W2022784448 hasConceptScore W2022784448C146357865 @default.
- W2022784448 hasConceptScore W2022784448C151730666 @default.
- W2022784448 hasConceptScore W2022784448C2776256026 @default.
- W2022784448 hasConceptScore W2022784448C2776808855 @default.
- W2022784448 hasConceptScore W2022784448C2777693549 @default.
- W2022784448 hasConceptScore W2022784448C2779720271 @default.
- W2022784448 hasConceptScore W2022784448C2779961022 @default.
- W2022784448 hasConceptScore W2022784448C2780325254 @default.
- W2022784448 hasConceptScore W2022784448C2993415550 @default.
- W2022784448 hasConceptScore W2022784448C71924100 @default.
- W2022784448 hasConceptScore W2022784448C86803240 @default.
- W2022784448 hasIssue "4" @default.
- W2022784448 hasLocation W20227844481 @default.
- W2022784448 hasLocation W20227844482 @default.
- W2022784448 hasOpenAccess W2022784448 @default.
- W2022784448 hasPrimaryLocation W20227844481 @default.
- W2022784448 hasRelatedWork W1858567978 @default.
- W2022784448 hasRelatedWork W1999790977 @default.
- W2022784448 hasRelatedWork W2043339645 @default.
- W2022784448 hasRelatedWork W2095630426 @default.
- W2022784448 hasRelatedWork W2144487355 @default.
- W2022784448 hasRelatedWork W2204690422 @default.
- W2022784448 hasRelatedWork W2312337491 @default.
- W2022784448 hasRelatedWork W2415099216 @default.
- W2022784448 hasRelatedWork W2586082208 @default.
- W2022784448 hasRelatedWork W312434847 @default.